Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · IEX Real-Time Price · USD
0.950
+0.020 (2.16%)
At close: Mar 28, 2024, 4:00 PM
0.990
+0.040 (4.21%)
After-hours: Mar 28, 2024, 4:12 PM EDT

Cytosorbents Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2006
Revenue
36.3534.6943.174124.9522.515.159.534.794.12
Upgrade
Revenue Growth (YoY)
4.79%-19.64%5.27%64.35%10.87%48.53%59.02%98.84%16.22%70.18%
Upgrade
Cost of Revenue
13.9613.9611.0511.057.367.495.523.952.212.13
Upgrade
Gross Profit
22.3920.7332.1229.9517.5915.019.635.572.581.99
Upgrade
Selling, General & Admin
37.8737.1438.4831.5124.4722.8816.2512.998.016.45
Upgrade
Research & Development
15.7315.1216.388.8112.097.723.224.073.872.43
Upgrade
Operating Expenses
53.652.2554.8640.3236.5630.619.4717.0711.888.88
Upgrade
Operating Income
-31.21-31.52-22.74-10.37-18.97-15.58-9.84-11.49-9.3-6.89
Upgrade
Interest Expense / Income
0.16-0.13-0.031.21.031.460.750.23-0.010.31
Upgrade
Other Expense / Income
-2.052.522.58-2.610.350.78-1.450.360.512.5
Upgrade
Pretax Income
-29.32-33.91-25.29-8.96-20.36-17.83-9.14-12.08-9.8-9.71
Upgrade
Income Tax
-0.81-1.09-0.74-1.13-1.09-0.62-0.68-0.32-0.32-0.39
Upgrade
Net Income
-28.51-32.81-24.56-7.84-19.27-17.21-8.46-11.76-9.48-9.32
Upgrade
Preferred Dividends
0000000.34009.27
Upgrade
Net Income Common
-28.51-32.81-24.56-7.84-19.27-17.21-8.8-11.76-9.48-18.59
Upgrade
Shares Outstanding (Basic)
45444339323128252514
Upgrade
Shares Outstanding (Diluted)
45444339323128252514
Upgrade
Shares Change
2.49%0.49%11.70%20.35%5.00%11.25%8.57%2.20%73.02%52.35%
Upgrade
EPS (Basic)
-0.64-0.75-0.57-0.20-0.60-0.56-0.32-0.46-0.38-1.29
Upgrade
EPS (Diluted)
-0.64-0.75-0.57-0.20-0.60-0.56-0.32-0.46-0.38-1.29
Upgrade
Free Cash Flow
-22.19-34.32-17.65-6.32-17.46-11.51-7.45-6.87-9.45-6.43
Upgrade
Free Cash Flow Per Share
-0.50-0.79-0.41-0.16-0.54-0.38-0.27-0.27-0.38-0.45
Upgrade
Gross Margin
61.60%59.77%74.41%73.05%70.48%66.72%63.58%58.50%53.82%48.24%
Upgrade
Operating Margin
-85.86%-90.87%-52.69%-25.29%-76.05%-69.25%-64.96%-120.62%-194.17%-167.19%
Upgrade
Profit Margin
-78.43%-94.59%-56.89%-19.11%-77.22%-76.48%-58.06%-123.46%-197.78%-450.86%
Upgrade
Free Cash Flow Margin
-61.06%-98.94%-40.88%-15.42%-69.97%-51.15%-49.18%-72.12%-197.25%-156.06%
Upgrade
EBITDA
-27.14-32.91-24.19-7.1-18.74-15.98-8.17-11.69-9.7-9.33
Upgrade
EBITDA Margin
-74.65%-94.86%-56.05%-17.32%-75.12%-71.01%-53.93%-122.68%-202.39%-226.34%
Upgrade
Depreciation & Amortization
2.031.131.130.660.580.390.220.160.110.07
Upgrade
EBIT
-29.16-34.04-25.32-7.76-19.32-16.37-8.39-11.85-9.81-9.4
Upgrade
EBIT Margin
-80.23%-98.12%-58.66%-18.93%-77.45%-72.74%-55.37%-124.37%-204.75%-227.93%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).